Fortress Biotech, Inc.
General ticker "FBIOP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $80.6M (TTM average)
Fortress Biotech, Inc. follows the US Stock Market performance with the rate: 43.3%.
Estimated limits based on current volatility of 0.6%: low 20.06$, high 20.32$
Factors to consider:
- Total employees count: 78 (-22.8%) as of 2025
- Top business risk factors: Clinical trial failure, Regulatory and compliance, Market competition, Inability to raise capital, Profitability
- Current price 185.8% above estimated high
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.73$, 7.79$]
- 2025-12-31 to 2026-12-31 estimated range: [2.59$, 7.08$]
Short-term FBIOP quotes
Long-term FBIOP plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $57.67MM | $63.26MM |
| Operating Expenses | $168.05MM | $133.48MM |
| Operating Income | $-110.38MM | $-70.22MM |
| Non-Operating Income | $-10.16MM | $36.69MM |
| Interest Expense | $9.93MM | $10.11MM |
| R&D Expense | $56.88MM | $11.90MM |
| Income(Loss) | $-120.54MM | $-33.53MM |
| Taxes | $0.31MM | $-0.62MM |
| Net Income(Loss)* | $-46.00MM | $6.82MM |
| Stockholders Equity | $22.74MM | $49.87MM |
| Inventory | $14.43MM | $9.62MM |
| Assets | $144.22MM | $185.55MM |
| Operating Cash Flow | $-80.19MM | $-65.78MM |
| Capital expenditure | $15.00MM | $0.00MM |
| Investing Cash Flow | $-15.00MM | $10.12MM |
| Financing Cash Flow | $70.64MM | $77.44MM |
| Earnings Per Share** | $-2.21 | $0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.